Release Date: 31/08/09 15:35 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 435.89KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%